ConductScience.org, home

Gene · 80331

Papers3,340

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Comparison of techniques and markers to distinguish Plasmodium falciparum recrudescence from new infection in Rwanda.Sci Rep202642270857PubTator, text miningPubMed
Determining whether barcodes on investigational compounded sterile products are scannable by an IV workflow management system.Am J Health Syst Pharm202642269100PubTator, text miningPubMed
Fc-fucosylation of Plasmodium falciparum-specific IgG varies with antigen and immunization.J Infect Dis202642262128PubTator, text miningPubMed
An Atypical Dinuclear Copper(II) 1,2,4-Triazolyl Complex as a Catalyst for Palladium-Free Csp-Csp Homocoupling of Phenylacetylene.ACS Org Inorg Au202642256435PubTator, text miningPubMed
Structural basis for conserved and distinct antigen recognition by a lineage of malaria-protective antibodies.PLoS Pathog202642234703PubTator, text miningPubMed
To explore molecular targets and combination antimalarial chemotherapeutics as tissue and erythrocytic schizonticides.J Parasit Dis202642226897PubTator, text miningPubMed
Odorant-binding proteins and chemosensory proteins in insects: structural insights, functional plasticity, and prospects for targeted pest management.Mol Biol Rep202642154068PubTator, text miningPubMed
Mannosylated nanoparticle immunogens enhance the circumsporozoite protein-specific B cell response and improve protection against sporozoite challenge.bioRxiv202642146683PubTator, text miningPubMed
PPARα and RXRα in the regulation of neuronal ceroid lipofuscinosis genes: implications for Batten disease therapy.NeuroImmune Pharm Ther202642146023PubTator, text miningPubMed
Antibody fine specificity correlates with protection from malaria for the RTS,S vaccine in young African children: A post hoc analysis of a phase IIb randomised controlled trial.PLoS Med202642133737PubTator, text miningPubMed
Radiofrequency Fields at 2.45 GHz Reprogram Mitochondria-Lysosome Crosstalk and Modulate the Survival/Death of Macrophages Exposed to LPS and/or the SARS-CoV-2 Spike Protein.Int J Mol Sci202642123398PubTator, text miningPubMed
Continental-scale genomic surveillance of Plasmodium falciparum malaria across sub-Saharan Africa with rapid nanopore sequencing.Nat Commun202642115168PubTator, text miningPubMed
Investigation of the three pectin fractions variation impact on the Maillard reaction in dried crabapple storage.Int J Biol Macromol202642092660PubTator, text miningPubMed
Relevance of the antibody Fc fragment and epitope valency in protection against malaria sporozoites.EMBO Rep202642045446PubTator, text miningPubMed
Haplotype diversity of Plasmodium falciparum circumsporozoite protein prior to malaria vaccine implementation in Kaelé Health District, Cameroon, 2022-2023.Front Parasitol202642023409PubTator, text miningPubMed
TDP43 and hnRNP K Regulate Alternative Splicing of DNAJC5.Cell Biol Int202641983529PubTator, text miningPubMed
Harnessing conserved epitopes and multivalent antigen strategies for vaccine design: Lessons learned and opportunities.Hum Vaccin Immunother202641914544PubTator, text miningPubMed
Population HLA coverage of experimentally characterized P. falciparum CD8 + T cell epitopes as potential components of a multi-epitope malaria vaccine construct: an in silico insight.Front Bioinform202641909811PubTator, text miningPubMed
Recent Advances, Bottlenecks, and Future Directions in Plasmodium falciparum Vaccine Development.Vaccines (Basel)202641893813PubTator, text miningPubMed
Takotsubo syndrome in the setting of cardiac pacing: A review of mechanistic and clinical perspectives.Heart Fail Rev202641857469PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/80331/papers?page=2